Cori-Fill fluid dosage assembly is fast and accurate
Mass flow metering and control specialist Bronkhorst, based in Cambridgeshire, UK, is offering an alternative to the gravimetric or weighing scale method of dosing additives, which promises shorter processing times, better product results and improved working atmospheres.
The company's Cori-Fill compact fluid dosage assembly, which combines a Cori-Flow or mini Cori-Flow flowmeter with a suitable valve or pump, is capable of dosing the exact amount of fluid, while multiple instruments can be used for the simultaneous dosing of compounds.
The instrument is suitable for batching, blending, dosing, filling and sterilisation applications at flow rates between 0.4g/hr and 600kg/hr. Aimed at the pharmaceutical, chemical and life sciences industries, among others, it takes up little room and requires no complex programming of additional hardware.
Unlike the conventional gravimetric method of dosing, which uses a shut-off valve and a weighing scale located under the valve's outlet nozzle, the Cori-Fill technology, with integrated batch counters and the facility to operate shut-off valves, is capable of dosing the precise amount of compound into the collecting vessel, with just a brief reset command to start the next batch.
The company says the Coriolis direct mass measurement method eliminates volumetric variation caused by changing temperatures, viscosities and densities of the ingredients, leading to accurate, repeatable quantities batch after batch.
Cori-Fill assemblies are offered with a choice of Cori-Flow instruments, for flow rates between 20g/hr to 600kg/hr, or the highly compact mini Cori-Flow series, for capacities from 0.4g/hr up to 30kg/hr. Either instrument type can be combined with a shut-off valve, for short batch sequences down to <0.3sec, a proportional valve, for longer dosing times >5 seconds, or a gear pump, for dosing without the need for pressurised vessels.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Semaglutide patent cliff: pharma industry braces for impact
Read moreWith the weight-loss industry shifting from a monopoly held by innovators to a high-volume, competitive generic market, the pharma manufacturing sector is gearing up for a "generic wave" with investments into large-scale protein synthesis and facilities for injectables
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more. -
You need to be a subscriber to read this article.
Click here to find out more.
Upcoming event
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Analysis
Semaglutide patent cliff: pharma industry braces for impact
With the weight-loss industry shifting from a monopoly held by innovators to a high-volume, competitive generic market, the pharma manufacturing sector is gearing up for a "generic wave" with investments into large-scale protein synthesis and facilities for injectables
Manufacturing
LabVantage Solutions introduces LabVantage CORTEX, advancing its LIMS platform for AI-driven laboratory operations
Next-Generation Platform Extends LIMS with Agentic AI and Cloud-Native Automation to Improve Efficiency, Reduce Errors and Gain Deeper Insight from Data. Learn More from LabVantage Leadership at Pittcon 2026
Manufacturing
Schütz to build automated IBC production facility at BASF's Ludwigshafen headquarters
Packaging specialist Schütz has signed an agreement with BASF to construct a highly automated intermediate bulk container manufacturing and storage facility directly adjacent to the chemical giant's main plant in Ludwigshafen, enabling round-the-clock just-in-time delivery
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
LGM Pharma announces $9 million investment into Colorado and Texas manufacturing facilities
The investment marks the second phase of the the company's expansion, funding facility upgrades to increase capacity for suppository, semi-solid and oral solid dose and differentiating LGM in the US CDMO market, says CEO Prasad Raje, speaking exclusively to Manufacturing Chemist
Manufacturing
SGD Pharma partners with Prince Sterilisation Services for pharmaceutical glass packaging
The pair have already launched the My Sterinity Nasal platform, a new, versatile sterile vial range within SGD Pharma's My Sterinity RTU platform, using the company's U-Save Type I vials, which are designed to support the growing segment of high-value nasal drug delivery